Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026GlobeNewsWire · Oct 15, 2026
Mobia Medical, Inc. (NASDAQ:MOBI) Stock Now Rated “Moderate Buy” by Sell-Side AnalystsDefense World · Oct 5, 2026
Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke GuidelinesGlobeNewsWire · Aug 28, 2026
Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call TranscriptSeeking Alpha · Aug 11, 2026
Mobia Medical Q2 Earnings Call HighlightsMarketBeat · Aug 11, 2026
Mobia Medical Reports Second Quarter 2026 Financial ResultsGlobeNewsWire · Aug 11, 2026Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 11, 2026 | -$0.71 | -$1.10 | Miss |
| Jun 4, 2026 | -$18.79 | -$0.53 | Beat |